J. THORNTON to Female
This is a "connection" page, showing publications J. THORNTON has written about Female.
Connection Strength
0.216
-
Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024 Dec 20; 21(1):220.
Score: 0.027
-
Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 May 30; 14(5):e082339.
Score: 0.026
-
Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062.
Score: 0.026
-
Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):511-517.e8.
Score: 0.023
-
Intention to get naloxone among?patients prescribed opioids for chronic pain. Harm Reduct J. 2022 Sep 22; 19(1):104.
Score: 0.023
-
Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S12-S18.e4.
Score: 0.016
-
Car Seat Safety: Typologies of Protective Health and Safety Behaviors for Mothers in West Virginia. Matern Child Health J. 2017 02; 21(2):326-334.
Score: 0.016
-
Re: Saunders R, Lian J, Karolicki B, Valentine W. The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial. J Med Econ 2014;17(12):827-36. J Med Econ. 2015 Jun; 18(6):433-4.
Score: 0.014
-
Impact of automated alerts on discharge opioid overprescribing after general surgery. Am J Health Syst Pharm. 2024 Dec 05; 81(24):1288-1296.
Score: 0.007
-
Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
Score: 0.007
-
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. Am J Clin Oncol. 2024 Nov 01; 47(11):517-525.
Score: 0.007
-
Trends and patterns in the use of opioids among metastatic breast cancer patients. Sci Rep. 2020 12 10; 10(1):21698.
Score: 0.005
-
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
Score: 0.005
-
Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist. 2020 10; 25(10):e1574-e1582.
Score: 0.005
-
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
Score: 0.005
-
Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study. J Opioid Manag. 2018 Sep/Oct; 14(5):317-326.
Score: 0.004